MAPT and Alzheimer disease: As GSK-3β has been revealed to phosphorylate tau, dysfunction of PI3K/AKT signaling causes GSK-3β hyper-activity and directs to tau hyper-phosphorylation, an important event in AD pathogenesis [72].